Protein and Strength Training for Menopause: What Works

Short answer: Lean mass declines about 0.5–1% per year from the fourth decade and accelerates around the final period. Protein at 1.2–1.6 g per kilogram per day, distributed across meals, combined with two to three progressive resistance sessions weekly, preserves lean mass and improves insulin sensitivity, bone density, and fall risk.

Protein targets that are actually achievable

Most women in midlife eat well under 1 g/kg per day, front-loaded toward dinner. Distribution matters: roughly 25–35 g per meal reaches the leucine threshold for muscle protein synthesis better than the same total eaten in one sitting.

How to train

Two to three sessions a week, whole body.
Compound movements: squat or leg press, hinge, push, pull, carry.
Progressive load — add weight or reps every one to two weeks.
Two to three sets per movement to near-failure is sufficient.

← Back to menopause weight gain: causes and treatment

Want a plan that protects muscle rather than just cutting calories? A Kindr clinician will review your labs, body composition goals, sleep, and eligibility for medication together.

Start your visit →

Not ready? Ask Dot, our free AI menopause companion.

Frequently asked questions

Will lifting make me bulky?

No. Postmenopausal women have low circulating androgens; resistance training produces strength and density, not size.

Is protein bad for my kidneys?

Not with normal kidney function. Adjust intake only under advice in advanced chronic kidney disease.

Menopause weight gain: causes and treatment

Mechanism, every treatment class, tools, evidence, and care. Start anywhere.

Pillar guide →Every option for midlife weight and metabolic change, ranked by the weight loss it produced in randomized trials — plus a metabolic-risk quiz, a time-to-result timeline, and an honest account of what hormone therapy does and does not do.Why menopause weight gain happens →Estradiol, visceral redistribution, lean-mass loss, and sleep — the mechanism in full.GLP-1 therapy in menopause →Semaglutide and tirzepatide: eligibility, trial effect sizes, side effects, muscle protection.Menopause belly fat →Visceral versus subcutaneous fat, why waist matters more than weight, and what shrinks it.Insulin resistance in menopause →Why glucose control worsens after the final period, what to test, and how to reverse it.Muscle, protein, and strength →Sarcopenia in midlife, protein targets, and how to train to keep lean mass.Diet patterns that work →Mediterranean, higher-protein, and time-restricted eating compared on real evidence.

Other Kindr symptom hubs

The brain fog hub →The menopause sleep hub →Peptide therapy: evidence, legality, and safety →The hot flashes hub →

Continue across the Kindr entity graph

Related evidence, peptides, and clinical tools on the same topic.

Sources

Jastreboff AM et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med 2022.
Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med 2021.
Lincoff AM et al. Semaglutide and cardiovascular outcomes in obesity without diabetes (SELECT). N Engl J Med 2023.
Greendale GA et al. Changes in body composition and weight during the menopause transition (SWAN). JCI Insight 2019.
Knowler WC et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002.
Estruch R et al. Primary prevention of cardiovascular disease with a Mediterranean diet (PREDIMED). N Engl J Med 2018.
The Menopause Society. 2022 Hormone Therapy Position Statement.

Educational content only — not a substitute for professional medical advice, diagnosis, or treatment. The severity quiz is a screening aid, not a diagnosis. Reviewed by the Kindr Health clinical team · Last reviewed 2026-07-26.